Zielen S, Wosniok J, Wollscheid N, Nickolay T, Grimmel C, Scheele D, Sattler F, Prenzel F, Lorenz M, Schaub B, Lex C, Dahlheim M, Trischler J, Donath H, Lau S, Hamelmann E, Vogelberg C, Gerstlauer M, Wetzke M, Schubert R, Schollenberger L, Gappa M
Department for Children and Adolescents, Goethe-University Frankfurt, Frankfurt, Germany.
Interdisciplinary Center for Clinical Trials (IZKS), University Medical Center Mainz, Mainz, Germany.
Front Pediatr. 2025 Mar 5;13:1558256. doi: 10.3389/fped.2025.1558256. eCollection 2025.
Children with preschool asthma suffer disproportionally more often from severe asthma exacerbations with emergency visits and hospital admissions than school children. However, there are only a few reports on characteristics, hospitalization, phenotypes and symptoms in this age cohort.
This analysis of an ongoing prospective trial of Tiotropium bromide in preventing severe asthma exacerbations (the TIPP study) assessed baseline characteristics, hospitalizations and symptoms in 100 children with severe preschool asthma. Children aged 1-5 years were analyzed at study enrollment and daily symptoms were recorded by an electronic diary [Pediatric Asthma Caregiver Diary (PACD)] for the following four weeks until randomization.
At enrollment, the total number of severe asthma exacerbations, defined as three days systemic steroid use or hospitalization in the last 24 months, was mean (±SD) 5.8 ± 5.7 and the test for respiratory and asthma control in kids (TRACK) was mean 46.9 ± 19.0. Daily recording of symptoms by the PACD revealed that only 7 patients were controlled at randomization, whereas 35 were partially and 58 were uncontrolled according to GINA.
Despite protective therapy with inhaled corticosteroids (ICS), most children of this severe asthma cohort were only partially or uncontrolled according to GINA guidelines.
学龄前哮喘儿童比学龄儿童更常因严重哮喘发作而频繁急诊就诊和住院。然而,关于这个年龄组的特征、住院情况、表型和症状的报告较少。
本分析来自一项正在进行的关于噻托溴铵预防严重哮喘发作的前瞻性试验(TIPP研究),评估了100例重度学龄前哮喘儿童的基线特征、住院情况和症状。对1 - 5岁儿童在研究入组时进行分析,并通过电子日记[儿科哮喘照顾者日记(PACD)]记录接下来四周直至随机分组时的每日症状。
入组时,过去24个月内定义为使用全身性类固醇三天或住院的严重哮喘发作总数平均(±标准差)为5.8 ± 5.7,儿童呼吸与哮喘控制测试(TRACK)平均为46.9 ± 19.0。PACD对症状的每日记录显示,随机分组时只有7例患者病情得到控制,而根据全球哮喘防治创议(GINA),35例为部分控制,58例未得到控制。
尽管使用吸入性糖皮质激素(ICS)进行了保护性治疗,但根据GINA指南,该重度哮喘队列中的大多数儿童仅部分得到控制或未得到控制。